CD44 and cholangiocarcinoma: In conclusion, this preliminary study demonstrates that while individual CD44 isoforms are not independent prognostic markers in cholangiocarcinoma, the complete absence of CD44s, v5, and v6 expression characterizes a potential “CD44s-v5-v6 Null” subtype.